` TRUL (Trulieve Cannabis Corp) vs S&P TSX Composite Index (Canada) Comparison - Alpha Spread

T
TRUL
vs
S
S&P TSX Composite Index (Canada)

Over the past 12 months, TRUL has underperformed S&P TSX Composite Index (Canada), delivering a return of -58% compared to the S&P TSX Composite Index (Canada)'s +23% growth.

Stocks Performance
TRUL vs S&P TSX Composite Index (Canada)

Loading
TRUL
S&P TSX Composite Index (Canada)
Add Stock
www.alphaspread.com

Performance Gap
TRUL vs S&P TSX Composite Index (Canada)

Loading
TRUL
S&P TSX Composite Index (Canada)
Difference
www.alphaspread.com

Performance By Year
TRUL vs S&P TSX Composite Index (Canada)

Loading
TRUL
S&P TSX Composite Index (Canada)
Add Stock

Competitors Performance
Trulieve Cannabis Corp vs Peers

S&P TSX Composite Index (Canada)
TRUL
LLY
JNJ
NOVO B
ROG
Add Stock

Trulieve Cannabis Corp
Glance View

Market Cap
1B CAD
Industry
Pharmaceuticals

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. The company is headquartered in Quincy, Florida and currently employs 9,000 full-time employees. The company went IPO on 2018-09-25. The firm is a multi-state operator in the United States operating in states, with market positions in Arizona, Florida, and Pennsylvania. The company is providing products across its brand portfolio and delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. The company operates in regulated markets that require knowledge in cultivation, manufacturing, retail and logistics. The firm utilizes critical ethanol extraction to obtain the cannabis oil used in its products. The company also utilizes carbon dioxide (CO2) extraction for terpene extraction as well as a line of CO2 vaporizer cartridges. The firm has developed a suite of products with stock keeping units (SKUs), including flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays.

TRUL Intrinsic Value
11.14 CAD
Undervaluation 52%
Intrinsic Value
Price
T
Back to Top